ClinicalTrials.Veeva

Menu
Unison Clinical Trials | Sherman Oaks, CA logo

Unison Clinical Trials | Sherman Oaks, CA

Research site

Site insights

Top conditions

Top treatments

Deucravacitinib
TAK-279
SCD-044
ESK-001
Zasocitinib
Ixekizumab
Ustekinumab
ABP 501
MD-7246
Guselkumab

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Contact this site

Linda Almaraz

Verified by this site

Active trials

8 of 24 total trials

A Study Comparing Zasocitinib (TAK-279) With Deucravacitinib in Adults With Plaque Psoriasis

The main aim of this study is to assess whether zasocitinib works better than deucravacitinib in treating participants with moderate-to-severe plaque...

Enrolling
Plaque Psoriasis
Drug: Zasocitinib
Drug: Placebo to match zasocitinib

The main aim of this study is to check the side effects of TAK-279 and how well it is tolerated in participants with moderate-to-severe plaque psoria...

Enrolling
Plaque Psoriasis
Drug: TAK-279

The goal of this clinical trial is to learn if ESK-001 works to treat moderate to severe plaque psoriasis. The main questions it aims to answer are:*...

Active, not recruiting
Plaque Psoriasis
Drug: Placebo
Drug: Apremilast

The objective of the ESK-001-018 long term extension is to evaluate the safety and efficacy of ESK-001 over time. The scientific questions it aims to...

Enrolling
Psoriasis
Severe Psoriasis
Drug: Open-Label ESK-001
Drug: Blinded ESK-001
Locations recently updated

A study to evaluate the long-term safety of Deucravacitinib versus Ustekinumab in participants with psoriasis

Enrolling
Plaque Psoriasis
Drug: Ustekinumab
Drug: Deucravacitinib

The purpose of this study is to determine the efficacy and safety of a monoclonal antibody, OpSCF, in the treatment of adults with moderate to severe...

Active, not recruiting
Atopic Dermatitis
Biological: Placebo
Biological: OpSCF

The purpose of the trial is to evaluate the safety, efficacy and immunogenicity of up to 3 intramuscular injections of the Acne mRNA vaccine candidat...

Enrolling
Acne
Other: Placebo
Biological: Acne mRNA vaccine

This is a multicenter, randomized, double-blind, placebo-controlled study in subjects with moderate to severe plaque psoriasis.

Active, not recruiting
Moderate to Severe Plaque Psoriasis
Drug: Placebo
Drug: SCD-044_Dose 3

Trial sponsors

A
Amgen logo
Bristol-Myers Squibb (BMS) logo
Exact Sciences Corporation logo
Sun Pharma logo
Takeda logo
AbbVie logo
A
A
Boehringer Ingelheim logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems